Why Attend
The Microbiome Invest Congress 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and health companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
“The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023)” Human Microbiome Market Industry Report
Pitch Your Microbes
CONGRATULATIONS to this year's Microbiome Invest ‘Pitch Your Microbes’ finalists!
Pitch Your Microbes showcases the most exciting emerging companies in microbiome - all nine of the finalists will pitch their innovative ideas to a room full of potential advisors, investors and partners on 23rd May.
Read more about them and their techologies in the Resources Secton below
This Year's Speakers
Dr Phil Bolton
Phil obtained his Ph.D in organometallic chemistry from the University of Durham in 2000 and subsequently joined P&G where he worked on new technology development for the hair colourant category. Phil then joined RB in 2006 and has worked across a number of Innovation and Category R&D ROLES IN THE UK, Italy, Singapore and the US, becoming a director in 2010 and returning back to the UK based RB HQ in April 2015.
Phil currently leads the Outside Innovation team and has responsibility for delivering new and innovative solutions to the Health category pipelines. This can be anything from an ingredient in the product, through to products themselves, forging sustainable partnerships as well as being a strategic innovation partner for the senior category leadership within RB.
Dr Morten L. Isaksen
Artem Khlebnikov
Artem Khlebnikov is Strategic Partnerships Director at the Danone Nutricia Research. In his role, he works closely with public and private partners and Danone R&I colleagues brining open innovation to help drive science-based opportunities that activate the Danone’s alimentation strategy and enable significant and sustainable growth opportunities aligned with Danone’s #OneHealth.OnePlanet approach.
Artem holds an MS degree in Chemical Engineering from the Mendeleev University of Chemical Technology, Moscow Russia, has completed his PhD in Biotechnology at the Swiss Federal institute of Technology in Lausanne and received Post-Doctoral training in Molecular Biology at University of California at Berkeley, USA.
Craig Thomson
Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.
Adrien Nivoliez
Johan van Hylckama Vlieg
Johan E.T. van Hylckama Vlieg is currently Senior Director Microbiome at Chr. Hansen AS, one of the largest microbe producing companies in the world. He is responsible for the microbiome innovation program and heading the microbiome research and pilot facility. He has 20 years of experience and leadership in gut microbiology, probiotics and food biotechnology in industry and academia. He is (co)author of more than 70 peer-reviewed publications and inventor of 13 patents or patent applications.
Arnaud Autret
Mike Romanos
Mike Romanos is a co-founder and Chief Executive of Microbiotica. He has 30 years’ experience in the biotech and pharma industry and previously co-founded Crescendo Biologics which he built and led as CEO and CSO, developing a leading antibody fragment discovery platform and pipeline in oncology and inflammation. Prior to that he held global VP roles in GlaxoSmithKline R&D over 10 years, during which time he formed and led major transnational divisions which helped shape the company’s discovery platforms and pipelines across therapeutic areas and modalities. In his last role he led a transnational group of 300 staff providing genomics, target and biomarker discovery, and platform biology for R&D. Mike is highly experienced in biotech translation and commercialisation, currently serving as a Non-Exec Director of the life-sciences charity LifeArc, and previously as Translational Adviser in Biomedicine at Imperial College, Venture Partner to UK Innovation and Science Seed Fund, and committee member on the MRC’s Developmental Pathway Funding Scheme for translational academic research. Mike holds a degree in Natural Sciences from Cambridge University, a PhD in Molecular Virology from Imperial College, and is a Fellow of the Royal Society of Biology.
Host
Legal Partner
Partners
Media Partners
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Book a Team to Save More!
Industry Rates Only: Team discounts cannot be combined with any other discount or offer
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
Enquiries about our pricing categories
Contact our team [email protected] or phone us on 02036962920 for more details.
Venue
Millennium Gloucester Hotel, 4-18 Harrington Gardens, Kensington, London SW7 4LH
The 3rd Annual Microbiome Invest Congress will be taking place at The Millennium Gloucester Hotel, who are also providing accommodation for our delegates.
Book with the code MICR230519 before the 22nd of May to receive the discounted room price of £200.
To book, you can either:
- Contact the direct reservations line on +44 207 331 6195
- Contact the main hotel line on +44 207 373 6030
- Contact the resevervations email: [email protected]
You can find out more about the hotel by clicking the image below.
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.